Quick Facts
FONT-SIZE Plus   Neg
Share SHARE

China Shenghuo Gets Opinion With Going Concern Qualification From Its Auditor

China Shenghuo Pharmaceutical Holdings, Inc. (KUN: Quote) said Friday that its audited consolidated financial statements for the fiscal year ended December 31, 2011, included in the company's Annual Report on Form 10-K filed with the Securities and Exchange Commission on March 30, 2012 contained a going concern qualification from its independent registered public accounting firm, Marcum Bernstein & Pinchuk LLP.

China Shenghuo is mainly engaged in the research, development, manufacture, and marketing of Sanchi-based medicinal and pharmaceutical, nutritional supplement and cosmetic products. Through its subsidiary, Kunming Shenghuo Pharmaceutical (Group) Co., Ltd., it owns thirty State Food and Drug Administration approved medicines, including the flagship product Xuesaitong Soft Capsules.

Click here to receive FREE breaking news email alerts for China Shenghuo Pharmaceutical Holdings Inc. and others in your portfolio

by RTT Staff Writer

For comments and feedback: editorial@rttnews.com

Business News

Editors Pick
A number of major retailers will be open on Thanksgiving for early Black Friday shopping events. Kohl's department stores will kick off Black Friday sales two hours earlier this year, at 6 p.m. Thanksgiving Day, while Macy's, Bon-Ton and Best Buy will open at the same time. J.C. Penney and Sears... Twitter Inc. has replaced its head of product Daniel Graf just six months after luring him over from Google, according to multiple reports. Graf, previously known for his work leading Google Maps, will retain his vice president of product title and work on Twitter's geolocation features, the Wall... LinkedIn Corp., the world's largest online professional network, said Thursday after the markets closed that its third quarter loss widened slightly from last year, as higher costs and expenses more than offset a 45% increase in revenue. However, the company's quarterly earnings per share, excluding items, came in above analysts' expectations as did its quarterly revenue.
comments powered by Disqus
FREE Newsletters, Analysis & Alerts

 

Stay informed with our FREE daily Newsletters and real-time breaking News Alerts. Sign up to receive the latest information on business news, health, technology, biotech, market analysis, currency trading and more.